| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1000473971 |
| P356 | DOI | 10.1007/BF00609813 |
| P953 | full work available at URL | http://link.springer.com/article/10.1007/BF00609813/fulltext.html |
| http://link.springer.com/content/pdf/10.1007/BF00609813.pdf | ||
| http://link.springer.com/content/pdf/10.1007/BF00609813 | ||
| P698 | PubMed publication ID | 4657650 |
| P2093 | author name string | A. Struppler | |
| P. Groneberg | |||
| P2860 | cites work | ??? | Q67218795 |
| Distribution of noradrenaline and dopamine (3-hydroxytyramine) in the human brain and their behavior in diseases of the extrapyramidal system | Q34248307 | ||
| The L-3,4-dioxyphenylalanine (DOPA)-effect in Parkinson-akinesia | Q34251567 | ||
| Dopamine and disease | Q35909204 | ||
| Functional role of the nigro-neostriatal dopamine neurons | Q42442278 | ||
| DEMONSTRATION AND MAPPING OUT OF NIGRO-NEOSTRIATAL DOPAMINE NEURONS. | Q42449524 | ||
| FURTHER EVIDENCE FOR THE PRESENCE OF NIGRO-NEOSTRIATAL DOPAMINE NEURONS IN THE RAT. | Q42449949 | ||
| A contribution to the biochemical treatment of the akinetic type of the Parkinson's syndrome | Q44398235 | ||
| Mental effects of high-dosage levodopa | Q44764025 | ||
| INFLUENCE OF LOCUS NIGER ON THE CONCENTRATION OF CATECHOLAMINES IN THE STRIATUM | Q46980953 | ||
| The influence of the nigro-neostriatal dopamine pathway on spinal motoneuron activity | Q48823467 | ||
| The nigrostriatal pathway: a correlative study based on neuroanatomical and neurochemical criteria in the cat and the monkey | Q48968647 | ||
| Decrease of cerebral 5-hydroxytryptamine by 3,4-dihydroxyphenylalanine after inhibition of extracerebral decarboxylase. | Q51190284 | ||
| Increase of Cerebral Catecholamines caused by 3,4-Dihydroxyphenylalanine after Inhibition of Peripheral Decarboxylase | Q51208477 | ||
| INFLUENCE OF THE SUBSTANTIA NIGRA ON THE CATECHOLAMINE CONTENT OF THE STRIATUM | Q51254894 | ||
| The effect of a new decarboxylase inhibitor on endogenous monoamines. | Q51287808 | ||
| Excretion of dopamine in diseases of basal ganglia. | Q51302153 | ||
| Occurrence and distribution of catechol amines in brain. | Q51312139 | ||
| Occurrence and distribution of dopamine in brain and other tissues. | Q51316949 | ||
| On the presence of 3-hydroxytyramine in brain. | Q51322287 | ||
| Catechol compounds in rat tissues and in brains of different animals. | Q51325237 | ||
| Effect of a decarboxylase inhibitor (Ro 4-4602) in combination with L-dopa on inhibited depressions | Q53758693 | ||
| Treatment of Parkinson's disease with L-dopa combined with a decarboxylase inhibitor | Q54257029 | ||
| L-dopa treatment failure: explanation and correction | Q55195310 | ||
| Current therapeutic problems of the parkinson syndrome | Q64946614 | ||
| Biochemical bases for the treatment of Parkinson's syndrome with L-dopa | Q67209122 | ||
| L-dopa in depressed patients. | Q67209866 | ||
| Effect of the combined treatment of Parkinson patients with L-Dopa and a decarboxylase inhibitor (Ro4-4602). Quantitative analysis of bradykinesia by means of reaction time measurements | Q67211169 | ||
| [Experimental results of the combined treatment of parkinsonism using L-DOPA and a decarboxylase inhibitory agent (Ro 4-4602)]. | Q67213399 | ||
| DEPRESSION DURING L-DOPA TREATMENT | Q67213442 | ||
| Treatment of Parkinsonism with oral L-DOPA combined with a decarboxylase inhibitor (Ro IV 46.02) | Q67215088 | ||
| Aromatic Amino Acids and Modification of Parkinsonism | Q67223978 | ||
| Stereotaxic methods of treatment | Q69204154 | ||
| Effect of L-DOPA on depression | Q70106392 | ||
| The effects of dopa on inhibited depressions | Q72965653 | ||
| Studies of adrenaline and noradrenaline in mammalian heart and suprarenals | Q76034822 | ||
| P433 | issue | 11 | |
| P407 | language of work or name | German | Q188 |
| P304 | page(s) | 492-496 | |
| P577 | publication date | 1972-11-01 | |
| P1433 | published in | The Science of Nature | Q324878 |
| P478 | volume | 59 |
| Q40305200 | Metabolism and properties of 3-methoxy-4-hydroxyphenylpyruvate; a metabolite of dihydroxyphenylalanine | cites work | P2860 |
Search more.